BRCA testing not offered to enough high-risk patients
A study has indicated that US doctors may not be recommending genetic testing to a sufficient number of high-risk breast cancer patients...
A study has indicated that US doctors may not be recommending genetic testing to a sufficient number of high-risk breast cancer patients...
The FDA has warned that it does not recommend the use of any currently available ovarian cancer screening tests to detect the disease...
by Amina Yonis
More than half of patients with sarcoma, a rare cancer, have mutations that are known to increase the risk of other types of cancer...
IVF treatment does not increase a woman's risk of developing breast cancer later in life, a study has found...
Researchers have developed a new pathway for genetically testing ovarian cancer patients which they say will save both lives and money...
Genetic mutations on several genes including BRCA2 have been associated with prostate cancer; while in a separate study, a BRCA1 mutation has been linked to a particular form of uterine cancer...
A drug currently used to treat osteoporosis in old age may help prevent breast cancer in women with a genetic predisposition for the disease...
Genetic-testing company Ambry Genetics has launched a huge database of cancer-patient genetics, freely available to the public...
More than 95 percent of younger women diagnosed with early-onset breast cancer are opting for genetic testing, a study has found...
US start-up company Sure Genomics has launched the first whole-genome testing service available directly to consumers, for a cost of $2500...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.